[go: up one dir, main page]

WO2011086182A3 - Pramipexole extended release tablets - Google Patents

Pramipexole extended release tablets Download PDF

Info

Publication number
WO2011086182A3
WO2011086182A3 PCT/EP2011/050542 EP2011050542W WO2011086182A3 WO 2011086182 A3 WO2011086182 A3 WO 2011086182A3 EP 2011050542 W EP2011050542 W EP 2011050542W WO 2011086182 A3 WO2011086182 A3 WO 2011086182A3
Authority
WO
WIPO (PCT)
Prior art keywords
extended release
release tablets
pramipexole extended
pramipexole
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2011/050542
Other languages
French (fr)
Other versions
WO2011086182A2 (en
Inventor
Asad Abukhalil
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthon BV
Original Assignee
Synthon BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon BV filed Critical Synthon BV
Priority to EP11700346A priority Critical patent/EP2525786A2/en
Publication of WO2011086182A2 publication Critical patent/WO2011086182A2/en
Publication of WO2011086182A3 publication Critical patent/WO2011086182A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

An extended-release pramipexole tablet can be formed with a neutral water swelling polymer, a water swelling anionic polymer, and optionally a water-soluble diluent.
PCT/EP2011/050542 2010-01-18 2011-01-17 Pramipexole extended release tablets Ceased WO2011086182A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP11700346A EP2525786A2 (en) 2010-01-18 2011-01-17 Pramipexole extended release tablets

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29601210P 2010-01-18 2010-01-18
US61/296,012 2010-01-18

Publications (2)

Publication Number Publication Date
WO2011086182A2 WO2011086182A2 (en) 2011-07-21
WO2011086182A3 true WO2011086182A3 (en) 2012-03-15

Family

ID=43799494

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2011/050542 Ceased WO2011086182A2 (en) 2010-01-18 2011-01-17 Pramipexole extended release tablets

Country Status (2)

Country Link
EP (1) EP2525786A2 (en)
WO (1) WO2011086182A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105796519A (en) * 2014-12-30 2016-07-27 浙江京新药业股份有限公司 Pramipexole dihydrochloride sustained-release tablet and preparation method thereof
CN106474084B (en) * 2015-08-28 2020-12-11 江苏先声药业有限公司 Pramipexole dihydrochloride sustained-release preparation and preparation method thereof
CN114939112B (en) * 2017-12-28 2024-03-01 北京北大维信生物科技有限公司 Pramipexole sustained-release pharmaceutical composition, preparation method and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050175691A1 (en) * 2002-07-25 2005-08-11 Lee Ernest J. Pramipexole once-daily dosage form
WO2006015944A2 (en) * 2004-08-13 2006-02-16 Boehringer Ingelheim International Gmbh Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof
WO2007090881A2 (en) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Modified release formulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE45735T1 (en) 1984-12-22 1989-09-15 Thomae Gmbh Dr K TETRAHYDRO-BENZTHIAZOLE, THEIR PRODUCTION AND USE AS INTERMEDIATE OR MEDICINAL PRODUCTS.
US20050226926A1 (en) 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050175691A1 (en) * 2002-07-25 2005-08-11 Lee Ernest J. Pramipexole once-daily dosage form
WO2006015944A2 (en) * 2004-08-13 2006-02-16 Boehringer Ingelheim International Gmbh Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof
WO2006015942A1 (en) * 2004-08-13 2006-02-16 Boehringer Ingelheim International Gmbh Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
WO2007090881A2 (en) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Modified release formulation

Also Published As

Publication number Publication date
EP2525786A2 (en) 2012-11-28
WO2011086182A2 (en) 2011-07-21

Similar Documents

Publication Publication Date Title
WO2012134613A3 (en) Pyridyldiamido transition metal complexes, production and use thereof
BRPI0816865A2 (en) Annular pressure monitoring during hydraulic fracturing.
EP2507452A4 (en) Pressure relief latch mechanism
WO2012006538A8 (en) Deuterated n-ethyl-n-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof
ZA201005118B (en) Aqueous polymer dispersions,method for the production and use thereof
PL2443483T3 (en) Multi-armed macromonomers, polymeric materials and contact lenses comprising same.
EP2449043B8 (en) Polyurethane-acrylic polymer dispersions and uses thereof
WO2011057224A3 (en) Zwitterionic polymer bioconjugates and related methods
USD699769S1 (en) Mold split insert
WO2014058967A3 (en) Anti-rotation system for box and pin connection
GB201305053D0 (en) Pressure sensing methods, devices and systems
EP2593763A4 (en) Pressure detection device
WO2012036842A3 (en) Pressure sensor configuration for pressurized tank
IN2014DN10578A (en)
EP3247781A4 (en) Soil release polymer in a solid sour
WO2011017128A3 (en) Multi-use cart
PL2638374T3 (en) Diaphragm assembly for a pressure sensor, and a pressure sensor provided with such assembly
WO2011117271A3 (en) Fungicidal mixtures based on azolopyrimidinylamines
WO2011124398A8 (en) Protective device for a pressure line, pressure line section and hydraulic system
IT1404855B1 (en) PRESSURE SWITCH WITH MANUAL RESET.
WO2011086182A3 (en) Pramipexole extended release tablets
GB201106016D0 (en) Polymers
WO2012001532A3 (en) Medical device with predefined activated cellular integration
WO2010047789A3 (en) Double sidewall angle nano-imprint template
GB2472676B (en) Monomers, polymers, dispersions and inks

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11700346

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2011700346

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE